Results 191 to 200 of about 191,380 (292)

Postoperative Effects of Celecoxib on Opioid Use and Pain Control After Benign Oropharyngeal Surgery

The Laryngoscope, EarlyView.
This study evaluated how the addition of celecoxib to a multimodal pain regimen following tonsillectomy + adenoidectomy, or uvulopalatopharyngoplasty (UPPP) + tonsillectomy affects postoperative opioid use and pain control. Patients who received celecoxib consumed significantly fewer opioids compared to the historic control group, with similar ...
Alana Platukus, Praneet Kaki, Anastasia Kaffenes, Udeerna Tippabhatla, Jared Robinson, Jaehee Kim, Erin Creighton, Meghan Crippen, Maurits Boon, Colin Huntley   +9 more
wiley   +1 more source

Mitigating Severe Ribociclib-Hepatotoxicity With Corticosteroids. [PDF]

Case Rep Oncol Med
Williamson J, Pletneva M, Kim RG, Bhatia R.   +3 more
europepmc   +1 more source

Cadaveric Renal Transplantation in Diabetics in the 1980's: with Special Reference to Cyclosporine. [PDF]

, 1983
Hakala, Thomas B, Iwatsuki, Shunzaburo, Rosenthal, J Thomas, Shaw, Byers W, Starzl, Thomas E   +4 more
core  

Immune-Related Polyradiculoneuropathy Associated With Immune Checkpoint Inhibitors: A Comprehensive Case Series. [PDF]

Brain Behav
Llauradó A, Lainez E, Ariño H, Gratacòs-Viñola M, Seoane JL, Roca-Herrera M, Restrepo-Vera JL, Sanchez-Tejerina D, Raguer N, Juntas-Morales R.   +9 more
europepmc   +1 more source

Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression [PDF]

, 1998
C Vivas, D McQuitty, H.A Gritsch, J McCauley, J McMichael, J.J Fung, M.L Jordan, P Randhawa, R Shapiro, R.L Simmons, Shapiro, Shapiro, Shapiro, Shapiro, Shapiro, Shapiro, Shapiro, Starzl, Starzl, Starzl, Starzl, T.E Starzl, T.R Hakala, V.P Scantlebury, W Irish   +24 more
core   +1 more source

Iatrogenic Cushing syndrome. [PDF]

JCEM Case Rep
Dogra P, Canale MC.
europepmc   +1 more source

Managing Alpha-Gal Allergy in a Case of Bioprosthetic TAVR. [PDF]

Case Reports Immunol
Patel R, Patel A, Biswas R, Hsieh B, Ramasamy D, Patel C.   +5 more
europepmc   +1 more source

Personalized Treatment of Patients With Multiple Sclerosis: A Case Report and Literature Review

Medicine Bulletin, EarlyView.
ABSTRACT Managing multiple sclerosis (MS) with a highly active disease course presents significant challenges, particularly regarding the timing of therapeutic escalation and the preservation of brain volume. We present a personalized management strategy for a 36‐year‐old male with relapsing‐remitting MS (RRMS) who experienced initial misdiagnosis ...
Fengjun Wang, Han Wang, Yu Zhang, Guoxun Zhang   +3 more
wiley   +1 more source

Induction treatment of lupus nephritis: to pulse or not to pulse? Whether 'tis nobler to universally or selectively prescribe. [PDF]

Lupus Sci Med
Gutowski E, Belmont HM.
europepmc   +1 more source

An Open‐Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease

Movement Disorders, EarlyView.
Complement activation is implicated in Huntington's disease; ANX005 is a potent inhibitor of component C1q. ANX005 exhibited a generally manageable safety profile with rapid reduction in C1q in the cerebrospinal fluid. Functional ability on composite Unified Huntington's Disease Rating Scale and total functional capacity was maintained, with potential ...
Rajeev Kumar, Pinky Agarwal, Karen Anderson, Daniel Claassen, Marissa Dean, Andrew Duker, Burton Scott, Benjamin Hoehn, Ann Mongan, Ping Lin, Ellen Cahir‐McFarland, Lori Taylor, Glenn Morrison, Ted Yednock, Sanjay Keswani, Henk‐Andre Kroon   +15 more
wiley   +1 more source